Rani Therapeutics Holdings, Inc.
RANI
$1.05
-$0.05-4.55%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -29.67M | -28.32M | -29.69M | -29.80M | -30.02M |
| Total Depreciation and Amortization | 900.00K | 980.00K | 1.02M | 1.03M | 1.03M |
| Total Amortization of Deferred Charges | 207.00K | 232.00K | 232.00K | 232.00K | 232.00K |
| Total Other Non-Cash Items | 2.89M | -412.00K | -2.03M | -4.03M | -6.19M |
| Change in Net Operating Assets | 6.96M | -148.00K | -544.00K | -1.68M | -544.00K |
| Cash from Operations | -18.71M | -27.66M | -31.01M | -34.24M | -35.50M |
| Capital Expenditure | -88.00K | -119.00K | -244.00K | -301.00K | -268.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -6.94M | 26.58M | 27.18M | 28.05M | 20.08M |
| Cash from Investing | -7.03M | 26.46M | 26.93M | 27.74M | 19.81M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -20.72M | -15.00M | -12.50M | -8.75M | -5.00M |
| Issuance of Common Stock | 119.89M | 16.92M | 24.07M | 20.29M | 20.37M |
| Repurchase of Common Stock | -59.00K | -47.00K | -54.00K | -70.00K | -47.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -4.47M | -810.00K | -1.74M | -1.74M | -1.74M |
| Cash from Financing | 40.30M | 1.07M | 9.78M | 9.73M | 13.59M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 14.56M | -133.00K | 5.70M | 3.23M | -2.10M |